These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9989739)

  • 1. Interferon beta treatment for multiple sclerosis.
    Herndon RM
    Lancet; 1999 Feb; 353(9151):494-5; author reply 497-8. PubMed ID: 9989739
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon beta treatment for multiple sclerosis.
    Goodin DS
    Lancet; 1999 Feb; 353(9151):495-6; author reply 497-8. PubMed ID: 9989741
    [No Abstract]   [Full Text] [Related]  

  • 3. Interferon beta treatment for multiple sclerosis.
    Galazka A
    Lancet; 1999 Feb; 353(9151):495; author reply 497-8. PubMed ID: 9989740
    [No Abstract]   [Full Text] [Related]  

  • 4. Interferon beta treatment for multiple sclerosis.
    O'Connor P
    Lancet; 1999 Feb; 353(9151):496; author reply 497-8. PubMed ID: 9989742
    [No Abstract]   [Full Text] [Related]  

  • 5. Interferon beta treatment in multiple sclerosis: the European clinical trials.
    Comi G; Martinelli V; Filippi M
    Mult Scler; 1996 Jul; 1(6):317-20. PubMed ID: 9345407
    [No Abstract]   [Full Text] [Related]  

  • 6. Neutralising antibodies against interferon beta in multiple sclerosis.
    Giovannoni G; Deisenhammer F
    Lancet; 2004 Jan; 363(9403):166-7; author reply 168-9. PubMed ID: 14726177
    [No Abstract]   [Full Text] [Related]  

  • 7. Alemtuzumab versus interferon beta-1a: implications for pathology and trial design.
    McFarland HF
    Lancet Neurol; 2009 Jan; 8(1):26-8. PubMed ID: 19081510
    [No Abstract]   [Full Text] [Related]  

  • 8. Interferon beta-1A for multiple sclerosis.
    Drug Ther Bull; 1998 Jan; 36(1):7-8. PubMed ID: 9614724
    [No Abstract]   [Full Text] [Related]  

  • 9. [Multiple sclerosis].
    Tanosaki M; Matsunaga M
    Nihon Rinsho; 2004 May; 62 Suppl 5():586-9. PubMed ID: 15197989
    [No Abstract]   [Full Text] [Related]  

  • 10. Interferon beta-1A for relapsing multiple sclerosis.
    Med Lett Drugs Ther; 1996 Jul; 38(979):63-4. PubMed ID: 8692073
    [No Abstract]   [Full Text] [Related]  

  • 11. Recombinant human interferon beta in the treatment of relapsing-remitting and secondary progressive multiple sclerosis.
    Sandberg-Wollheim M; Hommes OR; Hughes RA; Paty DW; Abdul-Ahad AK
    Mult Scler; 1995; 1 Suppl 1():S48-50. PubMed ID: 9345399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming multiple sclerosis trials into practical reality.
    Kieseier BC; Wiendl H
    Lancet Neurol; 2011 Jun; 10(6):493-4. PubMed ID: 21571592
    [No Abstract]   [Full Text] [Related]  

  • 13. Early treatment of multiple sclerosis with Rebif (recombinant human interferon beta): design of the study.
    Comi G; Barkhof F; Durelli L; Edan G; Fernandez O; Filippi M; Hartung HP; Hommes OR; Seeldrayers P; Soelberg-Sorensen P
    Mult Scler; 1995; 1 Suppl 1():S24-7. PubMed ID: 9345394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon beta treatment for multiple sclerosis.
    Johnson KP; Panitch HS
    Lancet; 1999 Feb; 353(9151):494; author reply 497-8. PubMed ID: 9989738
    [No Abstract]   [Full Text] [Related]  

  • 15. Interferons in the treatment of multiple sclerosis: errors and misrepresentations.
    Herndon RM
    Arch Neurol; 2000 Mar; 57(3):426-7. PubMed ID: 10714676
    [No Abstract]   [Full Text] [Related]  

  • 16. Interferon beta in multiple sclerosis. Interferon beta reduces overall relapse rate by one third.
    Napier JC
    BMJ; 1997 Feb; 314(7080):601. PubMed ID: 9055729
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiple sclerosis: early management.
    Zajicek J
    Br J Hosp Med; 1997 Feb 19-Mar 4; 57(4):137-40. PubMed ID: 9166373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interferon-beta treatment of progressive disseminated sclerosis. Is it possibly without effect?].
    Foldspang A
    Ugeskr Laeger; 1999 Aug; 161(31):4418-21. PubMed ID: 10487112
    [No Abstract]   [Full Text] [Related]  

  • 19. [Beta-interferon and multiple sclerosis].
    Clanet M
    Rev Neurol (Paris); 1993; 149(8-9):443-4. PubMed ID: 8009140
    [No Abstract]   [Full Text] [Related]  

  • 20. New treatments for multiple sclerosis.
    McDonald WI
    BMJ; 1995 Feb; 310(6976):345-6. PubMed ID: 7866205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.